157 related articles for article (PubMed ID: 32976909)
1. Structural Insights into N-terminal IgV Domain of BTNL2, a T Cell Inhibitory Molecule, Suggests a Non-canonical Binding Interface for Its Putative Receptors.
Basak AJ; Maiti S; Hansda A; Mahata D; Duraivelan K; Kundapura SV; Lee W; Mukherjee G; De S; Samanta D
J Mol Biol; 2020 Nov; 432(22):5938-5950. PubMed ID: 32976909
[TBL] [Abstract][Full Text] [Related]
2. N-terminal ectodomain of BTNL2 inhibits T cell activation via a non-canonical interaction with its putative receptor that results in a delayed progression of DSS-induced ulcerative colitis.
Hansda A; Goswami S; Mukherjee S; Basak AJ; Dasgupta S; Roy PK; Samanta D; Mukherjee G
Mol Immunol; 2024 Feb; 166():39-49. PubMed ID: 38219401
[TBL] [Abstract][Full Text] [Related]
3. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation.
Nguyen T; Liu XK; Zhang Y; Dong C
J Immunol; 2006 Jun; 176(12):7354-60. PubMed ID: 16751379
[TBL] [Abstract][Full Text] [Related]
4. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation.
Arnett HA; Escobar SS; Gonzalez-Suarez E; Budelsky AL; Steffen LA; Boiani N; Zhang M; Siu G; Brewer AW; Viney JL
J Immunol; 2007 Feb; 178(3):1523-33. PubMed ID: 17237401
[TBL] [Abstract][Full Text] [Related]
5. Regulation of costimulation in the era of butyrophilins.
Arnett HA; Escobar SS; Viney JL
Cytokine; 2009 Jun; 46(3):370-5. PubMed ID: 19380239
[TBL] [Abstract][Full Text] [Related]
6. Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells.
Swanson RM; Gavin MA; Escobar SS; Rottman JB; Lipsky BP; Dube S; Li L; Bigler J; Wolfson M; Arnett HA; Viney JL
J Immunol; 2013 Mar; 190(5):2027-35. PubMed ID: 23359506
[TBL] [Abstract][Full Text] [Related]
7. BTNL2-Ig Protein Attenuates Type 1 Diabetes in Non-Obese Diabetic (NOD) Mice.
Tian X; Lin Y; Cui C; Su M; Lai L
Adv Healthc Mater; 2019 May; 8(9):e1800987. PubMed ID: 30884196
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Disordered Regions and Their Roles in the Anti-Pathogenic and Immunomodulatory Functions of Butyrophilins.
Redwan EM; Al-Hejin AM; Almehdar HA; Elsaway AM; Uversky VN
Molecules; 2018 Feb; 23(2):. PubMed ID: 29401697
[TBL] [Abstract][Full Text] [Related]
9. Structural, mutational and biophysical studies reveal a canonical mode of molecular recognition between immune receptor TIGIT and nectin-2.
Samanta D; Guo H; Rubinstein R; Ramagopal UA; Almo SC
Mol Immunol; 2017 Jan; 81():151-159. PubMed ID: 27978489
[TBL] [Abstract][Full Text] [Related]
10. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.
Rigau M; Ostrouska S; Fulford TS; Johnson DN; Woods K; Ruan Z; McWilliam HEG; Hudson C; Tutuka C; Wheatley AK; Kent SJ; Villadangos JA; Pal B; Kurts C; Simmonds J; Pelzing M; Nash AD; Hammet A; Verhagen AM; Vairo G; Maraskovsky E; Panousis C; Gherardin NA; Cebon J; Godfrey DI; Behren A; Uldrich AP
Science; 2020 Feb; 367(6478):. PubMed ID: 31919129
[TBL] [Abstract][Full Text] [Related]
11. The T-Cell Inhibitory Molecule Butyrophilin-Like 2 Is Up-regulated in Mild Plasmodium falciparum Infection and Is Protective During Experimental Cerebral Malaria.
Subramaniam KS; Spaulding E; Ivan E; Mutimura E; Kim RS; Liu X; Dong C; Feintuch CM; Zhang X; Anastos K; Lauvau G; Daily JP
J Infect Dis; 2015 Oct; 212(8):1322-31. PubMed ID: 25883389
[TBL] [Abstract][Full Text] [Related]
12. Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells.
van der Merwe PA; McNamee PN; Davies EA; Barclay AN; Davis SJ
Curr Biol; 1995 Jan; 5(1):74-84. PubMed ID: 7697352
[TBL] [Abstract][Full Text] [Related]
13. Tim-4 inhibition of T-cell activation and T helper type 17 differentiation requires both the immunoglobulin V and mucin domains and occurs via the mitogen-activated protein kinase pathway.
Cao W; Ryan M; Buckley D; O'Connor R; Clarkson MR
Immunology; 2011 Jun; 133(2):179-89. PubMed ID: 21463297
[TBL] [Abstract][Full Text] [Related]
14. Structure and T cell inhibition properties of B7 family member, B7-H3.
Vigdorovich V; Ramagopal UA; Lázár-Molnár E; Sylvestre E; Lee JS; Hofmeyer KA; Zang X; Nathenson SG; Almo SC
Structure; 2013 May; 21(5):707-17. PubMed ID: 23583036
[TBL] [Abstract][Full Text] [Related]
15. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation.
Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y
Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636
[TBL] [Abstract][Full Text] [Related]
16. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
Bierer BE; Peterson A; Gorga JC; Herrmann SH; Burakoff SJ
J Exp Med; 1988 Sep; 168(3):1145-56. PubMed ID: 2459290
[TBL] [Abstract][Full Text] [Related]
17. Structural insight into T cell coinhibition by PD-1H (VISTA).
Slater BT; Han X; Chen L; Xiong Y
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1648-1657. PubMed ID: 31919279
[TBL] [Abstract][Full Text] [Related]
18. Homozygous variant rs2076530 of BTNL2 and familial sarcoidosis.
Coudurier M; Freymond N; Aissaoui S; Calender A; Pacheco Y; Devouassoux G
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):162-6. PubMed ID: 20560297
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Human and Murine T-Cell Immunoglobulin Mucin Domain 4 (TIM-4) IgV Domain Residues Critical for Ebola Virus Entry.
Rhein BA; Brouillette RB; Schaack GA; Chiorini JA; Maury W
J Virol; 2016 Jul; 90(13):6097-6111. PubMed ID: 27122575
[TBL] [Abstract][Full Text] [Related]
20. MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells.
Agrawal B; Gupta N; Konowalchuk JD
Front Immunol; 2018; 9():2391. PubMed ID: 30405607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
